Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Bonilla

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markersN K Cheung, B H Kushner, M P LaQuaglia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of ageB H Kushner, M P LaQuaglia, M A Bonilla, et al.
Blood|May 15, 1993
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropeniaD C Dale, M A Bonilla, M W Davis, et al.
Blood Cells|January 1, 1987
Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesisK Welte, M A Bonilla, J L Gabrilove, et al.
The Journal of Experimental Medicine|April 1, 1987
Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primatesK Welte, M A Bonilla, A P Gillio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of ageN K Cheung, B H Kushner, I Y Cheung, et al.
Blood|December 15, 1995
Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropeniaR Kalra, D Dale, M Freedman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Survival from locally invasive or widespread neuroblastoma without cytotoxic therapyB H Kushner, N K Cheung, M P LaQuaglia, et al.
Blood|September 26, 2000
Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropeniaD C Dale, R E Person, A A Bolyard, et al.
The New England Journal of Medicine|June 15, 1989
Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosisM A Bonilla, A P Gillio, M Ruggeiro, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markersN K Cheung, B H Kushner, M P LaQuaglia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of ageB H Kushner, M P LaQuaglia, M A Bonilla, et al.
Blood|May 15, 1993
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropeniaD C Dale, M A Bonilla, M W Davis, et al.
Blood Cells|January 1, 1987
Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesisK Welte, M A Bonilla, J L Gabrilove, et al.
The Journal of Experimental Medicine|April 1, 1987
Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primatesK Welte, M A Bonilla, A P Gillio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of ageN K Cheung, B H Kushner, I Y Cheung, et al.
Blood|December 15, 1995
Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropeniaR Kalra, D Dale, M Freedman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Survival from locally invasive or widespread neuroblastoma without cytotoxic therapyB H Kushner, N K Cheung, M P LaQuaglia, et al.
Blood|September 26, 2000
Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropeniaD C Dale, R E Person, A A Bolyard, et al.
The New England Journal of Medicine|June 15, 1989
Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosisM A Bonilla, A P Gillio, M Ruggeiro, et al.
Pageof 4